We at Aniserve are very proud to have obtained the marketing authorisation for Mirataz (r), a product for the treatment of cats, for the European Union, with the significant contribution of our Partner KLIFOVET on behalf of Kindred Biosciences, Inc, USA.

Dechra, a global animal health company, recently acquired the worldwide rights of the Mirataz® product portfolio from Kindred Biosciences.

Mirataz was launched in the United States in July 2018. It has recently been approved in the EU for bodyweight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions, and is expected to be launched in all European markets towards the end of the year 2020.

For all enquiries please contact: info.de@dechra.com